Canadian CDMO secures more funding to get its manufacturing site up and running
AtomVie Global Radiopharma Inc, a Canadian radiopharmaceutical contract manufacturer, has received additional funds to get its manufacturing facility up and running.
The manufacturer announced that it has raised an additional 90 million Canadian dollars ($66.9 million) in a “Tranche 2 Series A round,” led by the healthcare investment firm Avego Management. The company previously announced a $40 million Series A round last year, which contributed to the construction of a new 64,000-square-foot facility.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.